3 results match your criteria: "Huibei University of Medicine[Affiliation]"
Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway.
Reprod Biol Endocrinol
September 2022
Department of General Surgery, Taihe Hospital, Huibei University of Medicine, No. 32th, South Renmin Road, 442000, Shiyan City, Hubei Province, PR China.
Background: Circular RNAs (circRNAs) play a vital role in cancer progression. However, there are still numerous circRNAs that have not been functionally explored. Our study aimed to disclose the role of circ-CSNK1G1 in triple-negative breast cancer (TNBC).
View Article and Find Full Text PDFPilot trial of high-dose vitamin C in critically ill COVID-19 patients.
Ann Intensive Care
January 2021
Dept. of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Background: Few specific medications have been proven effective for the treatment of patients with severe coronavirus disease 2019 (COVID-19). Here, we tested whether high-dose vitamin C infusion was effective for severe COVID-19.
Methods: This randomized, controlled, clinical trial was performed at 3 hospitals in Hubei, China.
Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17.
Oncol Lett
June 2019
Department of Oncology, Xiangyang No. 1 People's Hospital, Huibei University of Medicine, Xiangyang, Hubei 441000, P.R. China.
Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on the levels of serum IL-17 were investigated. A retrospective analysis was performed on 129 patients who had metastatic gastric cancer after first-line chemotherapy and were treated in Xiangyang No. 1 People's Hospital from February 2012 to February 2015.
View Article and Find Full Text PDF